Get a practical framework for validating additive manufacturing processes and achieving audit-ready, regulated production.
The document will be sent to your email and you can review it at your own time, at any time.
May 4, 2026
Additive manufacturing is a proven manufacturing method across the medical device lifecycle— from early design validation through regulated production. As its role expands, the focus is no longer whether additive manufacturing works, but how it is governed, controlled, and defended in regulated manufacturing environments. In medical device production, inspection alone is often insufficient to ensure conformity. Regulators increasingly expect documented evidence that manufacturing processes are consistent, controlled, and suitable for their intended use. As a result, many manufacturers treat additive manufacturing as a special process, requiring structured validation aligned with ISO 13485 and FDA quality system expectations. This guide outlines how additive manufacturing validation is executed using an industry-recognized IQ/OQ/PQ (Installation, Operational, and Performance Qualification) framework, and how validated processes are governed and sustained over time.
Medical device manufacturers using additive manufacturing in regulated production must demonstrate:
Stratasys Direct applies a structured IQ/OQ/PQ validation framework supported by risk-based planning, disciplined process control, and regulated manufacturing practices.
IQ — Installation Qualification
Confirm equipment, calibration, and process readiness.
OQ — Operational Qualification
Establish process parameter limits and baseline capability.
PQ — Performance Qualification
Demonstrate repeatable, stable performance under production conditions. Validation establishes controlled production— not just documented execution.
Validation shifts quality from reactive inspection to controlled, predictable manufacturing.
Validated additive manufacturing requires more than technical capability—it requires disciplined, production-grade execution. Stratasys Direct provides:
This overview introduces how validated additive manufacturing supports controlled, audit-ready production in medical device manufacturing.
When additive manufacturing should be validated • How validation scope is defined using risk-based principles • What auditors expect to see in validated AM processes • How validated processes are governed and sustained over time • What to look for in a qualified additive manufacturing partner
Learn why Design for Additive Manufacturing (DFAM) is critical for scalable 3D printing. Discover how it reduces cost, improves part performance, and enables production-ready results.
View moreLearn when additive manufacturing is the right choice. Explore cost drivers, speed advantages, and production strategy in this practical AM guide.
View moreVisit Stratasys Direct at Booth #67 in Branson, MO, Feb. 23–25. See how additive manufacturing accelerates production from tooling and bridge parts to end-use components.
View moreLearn why Design for Additive Manufacturing (DFAM) is critical for scalable 3D printing. Discover how it reduces cost, improves part performance, and enables production-ready results.
Learn when additive manufacturing is the right choice. Explore cost drivers, speed advantages, and production strategy in this practical AM guide.
Visit Stratasys Direct at Booth #67 in Branson, MO, Feb. 23–25. See how additive manufacturing accelerates production from tooling and bridge parts to end-use components.